Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common
- PMID: 35313837
- PMCID: PMC8939208
- DOI: 10.1186/s12885-022-09407-5
Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common
Abstract
Background: The incidence of human papillomavirus (HPV) positive oropharyngeal cancer (OPC) is rising but HPV negative OPC is decreasing in Western countries. In Taiwan, the incidence of HPV negative OPC is common but the incidence of HPV positive OPC remains unknown. The objective of this study is to estimate the incidence trend and the survival of HPV positive OPC in Taiwan.
Methods: Between 1999 and 2014, primary tumor tissues from 425 incident OPCs were obtained from 5 medical centers in Taiwan. 408 OPCs were evaluated by the EasyChip HPV genotyping (King-Car, I-Lan, Taiwan) and 369 OPCs by p16 staining. The clinical data were retrospectively obtained from the medical records.
Results: In our study, 29% of OPCs were HPV positive. The percentage of HPV positive OPC was stable from 1999 to 2014 (25% (1999-2002), 30% (2003-2006), 30% (2007-2010), 29% (2011-2014)). The estimated crude incidence rate of HPV positive OPC increased significantly from 0.62 (1999-2002), 1.06 (2003-2006), 1.52 (2007-2010) to 1.74 (2011-2014) per 100,000 person-year. The sensitivity and specificity of p16 staining for positive HPV infection were 92% and 91%, respectively. The 5-year overall survival rates for patients with HPV positive OPC and with HPV negative OPC were 67.8% and 49.0%, respectively (HR = 0.52 (0.35-0.76), p = 0.0005). Patients with HPV positive OPC but no betel nut/cigarette exposure had the best overall survival (5-year: 88.2%, p < 0.0001). Patients with HPV negative OPC and betel nut/cigarette exposure had the worst overall survival (5-year: 46.6%, p < 0.0001). Patients with HPV positive OPC but also with betel nut/cigarette exposure had poorer 5-year overall survival (48.3%, p < 0.01).
Conclusion: The incidence of HPV positive OPC is increasing along with HPV negative OPC, which leads to stably low percentage of HPV positive OPC in Taiwan. HPV positive OPC may become an important head and neck cancer when the incidence of HPV negative OPC declines in the near future. P16 is a useful surrogate marker for HPV infection in OPC and a good prognostic indicator for treatment outcome of OPC. Patients with HPV positive OPC but no betel nut/cigarette exposure has an excellent prognosis. Betel nut/cigarette exposure significantly worsens the prognosis of HPV positive OPC.
Keywords: Betel nut; Human papillomavirus; Incidence; Oropharyngeal cancer; p16.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area.J Otolaryngol Head Neck Surg. 2023 Apr 20;52(1):27. doi: 10.1186/s40463-023-00632-x. J Otolaryngol Head Neck Surg. 2023. PMID: 37081578 Free PMC article.
-
Prevalence of current oral HPV infection among 100 betel nut chewers or cigarette smokers in Northern Taiwan.J Formos Med Assoc. 2019 Jan;118(1 Pt 1):203-208. doi: 10.1016/j.jfma.2018.03.013. Epub 2018 Apr 7. J Formos Med Assoc. 2019. PMID: 29636296
-
Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.Arch Otolaryngol Head Neck Surg. 2010 May;136(5):502-8. doi: 10.1001/archoto.2010.47. Arch Otolaryngol Head Neck Surg. 2010. PMID: 20479383
-
Oropharyngeal cancer - is it time to change management according to human papilloma virus status?Curr Opin Otolaryngol Head Neck Surg. 2012 Apr;20(2):120-4. doi: 10.1097/MOO.0b013e3283509735. Curr Opin Otolaryngol Head Neck Surg. 2012. PMID: 22327790 Review.
-
Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.Oral Oncol. 2010 Oct;46(10):705-11. doi: 10.1016/j.oraloncology.2010.07.006. Epub 2010 Sep 16. Oral Oncol. 2010. PMID: 20843732 Review.
Cited by
-
Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area.J Otolaryngol Head Neck Surg. 2023 Apr 20;52(1):27. doi: 10.1186/s40463-023-00632-x. J Otolaryngol Head Neck Surg. 2023. PMID: 37081578 Free PMC article.
-
A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation.Eur Arch Otorhinolaryngol. 2024 Jan;281(1):369-377. doi: 10.1007/s00405-023-08187-3. Epub 2023 Aug 18. Eur Arch Otorhinolaryngol. 2024. PMID: 37594545
-
Feasibility of Using Needle Rinse Fluid for Cobas Human Papillomavirus (HPV) Assay in Diagnosing HPV+ Oropharyngeal Cancer with Neck Lymph Node Aspiration.Ann Surg Oncol. 2024 Dec;31(13):9117-9124. doi: 10.1245/s10434-024-16058-2. Epub 2024 Aug 17. Ann Surg Oncol. 2024. PMID: 39154160
-
Prediction of Occult Contralateral Nodal Metastasis in Surgical Treated p16 Negative Oropharyngeal Squamous Cell Carcinoma.Cancer Manag Res. 2022 Nov 10;14:3151-3158. doi: 10.2147/CMAR.S382394. eCollection 2022. Cancer Manag Res. 2022. PMID: 36386552 Free PMC article.
-
What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials.Front Oncol. 2022 Dec 23;12:1067321. doi: 10.3389/fonc.2022.1067321. eCollection 2022. Front Oncol. 2022. PMID: 36620554 Free PMC article.
References
-
- Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–4301. doi: 10.1200/JCO.2011.36.4596. - DOI - PMC - PubMed
-
- Ragin C, Liu JC, Jones G, Shoyele O, Sowunmi B, Kennett R, Groen HJ, Gibbs D, Blackman E, Esan M, Brandwein MS, Devarajan K, Bussu F, Chernock R, Chien CY, Cohen MA, Samir EM, Mikio S, D'Souza G, Funchain P, Eng C, Gollin SM, Hong A, Jung YS, Krüger M, Lewis J, Jr, Morbini P, Landolfo S, Rittà M, Straetmans J, Szarka K, Tachezy R, Worden FP, Nelson D, Gathere S, Taioli E. Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients. Carcinogenesis. 2017;38:218–229. doi: 10.1093/carcin/bgw203. - DOI - PMC - PubMed
-
- Kreimer AR, Chaturvedi AK, Alemany L, Anantharaman D, Bray F, Carrington M, Doorbar J, D'Souza G, Fakhry C, Ferris RL, Gillison M, Neil Hayes D, Hildesheim A, Huang SH, Kowalski LP, Lang Kuhs KA, Lewis J, Jr, Lowy DR, Mehanna H, Ness A, Pawlita M, Pinheiro M, Schiller J, Shiels MS, Tota J, Mirabello L, Warnakulasuriya S, Waterboer T, Westra W, Chanock S, Brennan P. Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncol. 2020;108:104736. doi: 10.1016/j.oraloncology.2020.104736. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources